Bactiguard was one of four finalists to the AllBright Prize, awarded to the company on the Stockholm Stock Exchange, which made the most significant effort in driving the company towards more equality during the past year. "Common to the four finalists is that they all show that gender equality is a priority and work hard to reduce discrimination...
According to the World Health Organization antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Without urgent action, we are heading for a future in which infections and minor injuries could...
Recently, a portrait of Bactiguard's innovator, Billy Södervall, was unveiled at Bactiguard's headquarters in Botkyrka. The portrait, painted by the renowned Swedish artist Urban Larsson is a tribute to the innovator and founder of Bactiguard's unique infection prevention technology. "Billy Södervall is the DNA of Bactiguard, he is the founder...
In collaboration with the Swedish Urological Society (SUF), Bactiguard has awarded a scholarship of SEK 10 000 to Klara Elfsten and Pernilla Sundqvist from the Urological Clinic at the University Hospital of Örebro. The award ceremony took place during the closing of the Urology Days (Urologidagarna) in Gothenburg last week. The purpose of...
Yesterday at the ongoing "Urologidagarna" (Urology Days), arranged by the Swedish Urological Society, a Swedish study was presented about Bactiguard's Infection Protection Foley Catheter Silicone (BIP Foley). The study shows that 28 out 31 patients, who switched from a standard catheter to the BIP Foley Catheter, felt that the change led to both...
The sixth annual World Sepsis Day will be held on September 13th, 2017 by supporters in over 90 countries with Bactiguard as an official sponsor. World Sepsis Day is an opportunity for people across the world to unite in the fight against sepsis. In an effort to reduce the global burden of preventable sepsis, the Global Sepsis Alliance and the...
During the ongoing SSAI * congress in Malmö, a study was presented on Bactiguard's Infection Protection central venous catheter - BIP CVC. Less adverse events were reported in the Bactiguard group compared to the control group. The study also showed that Bactiguard's noble metal alloy does not pose a patient or environmental risk. The study was...
On June 29, 2017, the prestigious New England Journal of Medicine published an article detailing the Global Sepsis Alliance’s (GSA) perspective on the World Health Organization (WHO) resolution on improving the prevention, diagnosis, and management of sepsis. The term “sepsis” dates to at least the time of Hippocrates, who considered it the...
Shahrzad Kiavash was anesthetized for almost 2 weeks and stayed in the hospital for seven months. Both her lower legs were amputated. Sepsis almost cost her life. Today, Shahrzad Kiavash competes in triathlon – where swimming, cycling and running are all included in the same race. “It was as if my body was in overdrive, I wanted to escape from...
Every year 40 000 Swedes suffer from sepsis, with mortality rates as high as 20 percent. Even though the disease is almost as common as cancer, few Swedes have ever heard of it. Adam Linder, a researcher in internal medicine at the University of Lund, has been awarded the prestigious Global Sepsis Award 2017 by the Global Sepsis Alliance for his...
On 26 May 2017, the World Health Organization (WHO) agreed on a resolution to improve the prevention, diagnosis and treatment of sepsis. The resolution urges governments to strengthen their policies in infection prevention and to decrease the spread of antimicrobial resistance. The resolution itself focuses on the following key preventive actions:...
The World Health Assembly Side Event on Sepsis will take place on May 24th in Geneva. It will be jointly hosted by the Global Sepsis Alliance, the German Ministry of Health and the International Alliance of Patients’ Organizations. This event is taking place on the occasion of the 70th World Health Assembly passing a resolution on sepsis,...
There is currently a global shortage of last resort antibiotics due to a factory explosion in China a few months ago. The factory was one of the few that produces the raw materials for piperacillin / tazobactam, a kind of antibiotic given to hospitalized patients with severe infections, including sepsis. The occurrence of this global shortage...
Bactiguard and Biodina are currently attending the 14th International Sepsis Forum organized by the Latin American Sepsis Institute being held in Sao Paolo, Brazil on May 4 – 5 2017. The program seeks to bring together current research, challenges and interventions that are fundamental for the treatment of patients with sepsis in Latin America....
Bactiguard is not only committed to improving quality of life for patients but also for local communities, including in Botkyrka, where our headquarters are based. We have recently become a proud of sponsor of Företag Tillsammans mot Sexövergrepp (Companies Together against Sexual Abuse of Children). FTS provide free seminars and education to...
Bactiguard is now a proud sponsor of World Sepsis Day initiated by the Global Sepsis Alliance. Sepsis is the main cause of death from infection and affects more than 30 million people a year; of whom 6 to 8 million die. In Sweden, almost 40,000 people suffer from sepsis per year.[1] Surviving patients suffer from the consequences for the rest of...
The Infectious Diseases Society of America has recently released a report titled Faces of Antimicrobial Resistance, a compilation of patient stories that shows the reality of antimicrobial resistance and its impact on actual lives. Moving beyond data and statistics, the report delves into how antimicrobial resistant infections first appeared in...
A recent in-depth review published in the Journal of the Pediatric Infectious Diseases Society (Oxford University Press) has identified extremely high rates of antimicrobial resistance to bloodstream infections in neonates and children in India. In a survey of over 50,000 reported blood cultures, almost one-third (29.1%) were positive for...
In Life Science Sweden Issue No 1 March 2017, Bactiguard’s CEO Christian Kinch presents our simple idea: Preventing Health Care related infections caused by medical devices. Read the article
A study published by The Lancet Infectious Diseases found that the prevalence of healthcare-associated infections (HAI) was the highest in pediatric intensive care units (ICUs) with one in six children having an infection. In neonatal ICUs, 1 in 10 babies were infected. The study was based on data from the European Center for Disease Control...
Urinary tract infections resulting from the use of indwelling urinary catheters are one of the most common healthcare associated infections, causing patient suffering and a large financial strain on healthcare systems. These infections can also result in more serious complications such as bloodstream infections with high mortality rates. These...
